Robert F. Werner - 03 Feb 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Signature
/s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner
Issuer symbol
TWST
Transactions as of
03 Feb 2026
Net transactions value
-$327,687
Form type
4
Filing time
05 Feb 2026, 16:05:11 UTC
Previous filing
10 Dec 2025
Next filing
11 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WERNER ROBERT F. Chief Accounting Officer C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO /s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner 05 Feb 2026 0001590947

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale $8,151 -175 -0.27% $46.58 65,738 03 Feb 2026 Direct F1
transaction TWST Common Stock Sale $319,536 -7,000 -11% $45.65 58,738 04 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $45.61 to $45.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.